4.44
전일 마감가:
$4.53
열려 있는:
$4.53
하루 거래량:
769.17K
Relative Volume:
1.19
시가총액:
$430.14M
수익:
-
순이익/손실:
$-238.77M
주가수익비율:
-0.1656
EPS:
-26.808
순현금흐름:
$-216.62M
1주 성능:
+10.45%
1개월 성능:
+3.26%
6개월 성능:
-34.99%
1년 성능:
-56.85%
Alumis Inc Stock (ALMS) Company Profile
명칭
Alumis Inc
전화
650-231-6625
주소
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
ALMS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ALMS
Alumis Inc
|
4.44 | 471.41M | 0 | -238.77M | -216.62M | -26.81 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-25 | 개시 | Wells Fargo | Overweight |
2025-06-10 | 재개 | Guggenheim | Buy |
2025-01-30 | 개시 | Oppenheimer | Outperform |
2024-10-31 | 개시 | Robert W. Baird | Outperform |
2024-10-17 | 개시 | H.C. Wainwright | Buy |
2024-07-23 | 개시 | Cantor Fitzgerald | Overweight |
2024-07-23 | 개시 | Guggenheim | Buy |
2024-07-23 | 개시 | Leerink Partners | Outperform |
2024-07-23 | 개시 | Morgan Stanley | Overweight |
모두보기
Alumis Inc 주식(ALMS)의 최신 뉴스
Statistical indicators supporting Alumis Inc.’s strengthQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
Is Alumis Inc. still worth holding after the dipWeekly Market Outlook & Momentum Based Trading Ideas - newser.com
Using Bollinger Bands to evaluate Alumis Inc.Portfolio Value Summary & AI Enhanced Market Trend Forecasts - newser.com
Trend analysis for Alumis Inc. this weekWall Street Watch & Long-Term Capital Growth Strategies - newser.com
Is Alumis Inc. stock poised for growthDollar Strength & Short-Term Trading Alerts - newser.com
Analyzing recovery setups for Alumis Inc. investorsTrade Performance Summary & Low Drawdown Investment Ideas - newser.com
Will Alumis Inc. stock recover after recent dropIndex Update & Precise Buy Zone Tips - newser.com
Developing predictive dashboards with Alumis Inc. dataJuly 2025 Outlook & Short-Term Trading Alerts - newser.com
Is Alumis Inc. stock overvalued by current metricsInsider Buying & Short-Term High Return Ideas - newser.com
What analysts say about Alumis Inc stockVolume Spike Alerts & Expert-Backed Recommendations That Deliver - earlytimes.in
Alumis (NASDAQ:ALMS) Earns Sell (E+) Rating from Weiss Ratings - MarketBeat
Following a 56% Decline Over Last Year, Recent Gains May Please Alumis Inc. (NASDAQ:ALMS) Institutional Owners - 富途牛牛
Alumis Insiders Still US$77k Away From Original Investment Value - simplywall.st
Sector ETF performance correlation with Alumis Inc.Market Performance Summary & Technical Confirmation Trade Alerts - newser.com
What moving averages say about Alumis Inc.Weekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com
What analyst consensus says on Alumis Inc. stockWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Alumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
How to monitor Alumis Inc. with trend dashboardsPortfolio Update Summary & Advanced Swing Trade Entry Plans - newser.com
Analyzing net buyer seller activity in Alumis Inc.Rate Cut & Real-Time Volume Analysis Alerts - newser.com
What Is the Future of Sri Chakra Cement Limited Stock Expert Projections ExplainedMomentum Stock Picks & Affordable Market Insights - earlytimes.in
Is Alumis Inc a good long term investmentEarnings Miss Alerts & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
What recovery options are there for Alumis Inc.July 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Alumis Inc (ALMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alumis Inc 주식 (ALMS) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Tananbaum James B. | Director |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
Foresite Labs, LLC | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
Foresite Labs, LLC | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
Foresite Capital Management VI | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
Foresite Capital Management VI | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
AKKARAJU SRINIVAS | Director |
May 05 '25 |
Buy |
4.67 |
160,370 |
749,676 |
3,586,788 |
AKKARAJU SRINIVAS | Director |
May 02 '25 |
Buy |
4.55 |
159,920 |
727,636 |
3,426,418 |
Colowick Alan | Director |
Apr 01 '25 |
Buy |
6.97 |
16,104 |
112,309 |
16,104 |
Colowick Alan | Director |
Apr 02 '25 |
Buy |
7.49 |
2,300 |
17,235 |
18,404 |
Babler Martin | President, CEO and Chairman |
Apr 01 '25 |
Buy |
6.44 |
15,650 |
100,733 |
106,454 |
자본화:
|
볼륨(24시간):